← FDA Drug Approvals (Drugs@FDA)
ELITEK
BLA · Biologics License Application · Sponsor: SANOFI SYNTHELABO · Approved 2002-07-12
Drug application
- FDA Application #
BLA103946- Application type
- Biologics License Application
- Brand name
- ELITEK
- Generic name
- RASBURICASE
- Active ingredients
- RASBURICASE
- Dosage form
- VIAL
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SANOFI SYNTHELABO
- Manufacturer
- Sanofi-Aventis U.S. LLC
- First approval
- 2002-07-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown